Life Sciences Research for Lifelong Health



EMBO selects Babraham Immunologist for its prestigious Young Investigator Programme

Marc Veldhoen, Group Leader at the Babraham Institute, has been selected as one of 22 new scientists to join the prestigious EMBO Young Investigator Programme, which aims to support the career development of Europe’s most promising young researchers. “The EMBO Young Investigators have the potential to be tomorrow’s life science leaders,” says Gerlind Wallon, EMBO Deputy Director and manager of the Young Investigator Programme. “They are already active contributors to science in Europe and, by supporting them, EMBO wants to highlight both their work and their potential.” Selected for excellence in research from 164 applications in 2011, the scientists join a growing network of more than 300 young group leaders with access to a comprehensive array of networking, training, mentorship and funding opportunities. EMBO Members act as mentors to the Young Investigators, helping them to develop their careers. The young scientists join a dynamic network of current and former young investigators and installation grantees that encourages collaboration. Marc, who joined the Babraham Institute in 2010, joins an internationally-regarded team of immunologists, carrying out research to identify the molecular and biochemical mechanisms required for the development of the immune system and how immune function changes during ageing. Babraham’s Director, Professor Michael Wakelam, said, “We are delighted that Marc has been selected for this prestigious scheme supporting the career development of some of Europe’s most promising researchers. His recent research, revealing how dietary insufficiencies can adversely impact the immune system, is bringing new insight to understanding the basis of intestinal inflammatory disorders. A greater understanding of immunity and how the immune system is established is central to the goal of promoting a healthier lifespan.” The Babraham Institute, which receives strategic funding from BBSRC, undertakes world-leading life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Recent research has brought new insight that will inform strategies for combating autoimmune diseases, developing tumour immunotherapy and vaccine development. 22 young researchers join the EMBO Young Investigator Programme (pdf) Contact The Knowledge Exchange Office Email: Tel:       +44 (0)1223 496206 The Babraham Institute Babraham Research Campus Cambridge CB22 3AT United Kingdom   Notes to Editors: The Babraham Institute The Babraham Institute, which receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), undertakes international quality life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. The institute received £22.4M investment from BBSRC in 2010-11. The Institute’s research provides greater understanding of the biological events that underlie the normal functions of cells and the implication of failure or abnormalities in these processes. Research focuses on signalling and genome regulation, particularly the interplay between the two and how epigenetic signals can influence important physiological adaptations during the lifespan of an organism. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and healthier ageing. ( About BBSRC The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond. Funded by Government, and with an annual budget of around £445M, we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals. For more information about BBSRC, our science and our impact see: For more information about BBSRC strategically funded institutes see: About EMBO: EMBOEMBO stands for excellence in the life sciences. The organization enables the best science by supporting talented researchers, stimulating scientific exchange and advancing policies for a world-class European research environment. EMBO is an organization of 1500 leading life scientist members that fosters new generations of researchers to produce world-class scientific results. EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in cutting-edge techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information: For more information:


10 November, 2011